Web Stats Provided By Google Analytics

Monday, July 1, 2013

Mylan Inc. and Zyomyx, Inc. Enter into Exclusive Distribution...

CD4 count testing is a critical diagnostic component in treating HIV/AIDS, as medical professionals refer to a patient's CD4 count to determine when to begin and/or alter HIV treatment.

http://www.biospace.com/news_story.aspx?StoryID=301580&full=1

No comments:

Post a Comment